Email
Print
Market Overview:
The Smart Diabetes Management Market size is estimated to reach $40.9 billion by 2031, growing at a CAGR of 18.4% during the forecast period 2025-2031, according to a recent report published by IndustryARC, titled, “Smart Diabetes Management Market – By Product Type (Smart Glucose Meters, Continuous Glucose Monitors (CGMs), Smart Insulin Pens, Insulin Pumps, Wearables, Diabetes Management Apps and Others), By Connectivity (Bluetooth, NFC, WiFi and Others), By Application (Type 1 Diabetes and Type 2 Diabetes), Patient Demographics (Pediatric, Adult, Geriatric), By End User (Hospitals & Clinics, Diagnostic Centers and Home Care Settings), By Distribution Channel (Offline and Online) and By Geography - Global Opportunity Analysis & Industry Forecast, 2025-2031”
The rising prevalence of type 1 and type 2 diabetes is fuelling the demand for efficient diabetes management systems, Smart Diabetes Management helps monitor blood glucose levels to reduce the risk of hypoglycemia and hyperglycemia. Additionally, the awareness about usage of smart medical devices further boosts the need for Smart Diabetes Management.
North America Dominated the Market in 2024:
North America accounted for the largest share of 37% of the Smart Diabetes Management Market in 2024 due to increasing prevalence of diabetes, healthcare spending and insurance for devices to manage diabetes. North America, particularly the United States, faces a high prevalence of diabetes. According to the CDC’s (Centers for Disease Control) National Diabetes Statistics Report for 2022, cases of diabetes have risen to an estimated 37.3 million. 11.3% of the U.S. population has diabetes. As such, there is a growing need for smart diabetes management solutions.
Smart Diabetes Management Market: Key Takeaways
Rising Prevalence of Diabetes
The increasing global prevalence of diabetes is a major driver for smart diabetes management solutions. According to the International Diabetes Federation’s Annual Report 2023, 540 million people worldwide have diabetes. The global diabetic population set to reach around 700 million by 2045. This growing burden necessitates more efficient, real-time monitoring and management solutions. Smart glucose meters, CGMs and AI-powered diabetes management apps help patients monitor and control their blood sugar levels more effectively, and thereby reduce complications and hospitalizations.
For More Queries About "Smart Diabetes Management Market " @ https://www.industryarc.com/reports/request-quote?id=511236
Growing Demand for Smart Medical Devices to Manage Diabetes
With the rise of digital health technologies, patients and healthcare providers are turning to connected devices that offer real-time data monitoring, remote access and personalized insights. Smart glucose meters, CGMs, insulin pumps and diabetes management apps are revolutionizing the way diabetes is managed. These devices improve patient convenience and also enable proactive intervention which reduces the risk of complications. The growing integration of IoT and AI in healthcare further enhances device accuracy and usability.
Scope of the Report:
Recent Developments:
- In Novemeber 2024, Medtronic plc announced FDA clearance for its new InPen app featuring missed meal dose detection. With this clearance, the system will be the first in the market to recommend corrections for missed or inaccurate insulin doses, providing real-time, personalized insights for individuals on multiple daily injection (MDI) therapy.
- In August 2024, Dexcom launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market.
Smart Diabetes Management Market: Competitive Landscape
Key companies profiled in the Smart Diabetes Management Market are Medtronic plc, Eli Lilly and Company, Sanofi S.A., F. Hoffmann-La Roche AG, Novo Nordisk A/S, Abbott Laboratories, Dexcom, Inc., Ascensia Diabetes Care, Insulet Corporation, Glytec and Others
Related Reports:
The Diabetes Injection Pens Market - The Diabetes Injection Pens Market Size is estimated to reach $11.2 billion by 2028 and it is poised to grow at a CAGR of 6.1% over the forecast period of 2023-2028. The market is primarily driven due to the growing cases of diabetes.
Human Insulin Market - Human Insulin Market size is forecast to reach $27.81 billion by 2025, growing at a CAGR of 5.4% during the forecast period 2020-2025. The rising number of diabetic patients and technological advancements in insulin delivery devices are the major factors driving the growth of the market.
Glucose Sensor Market- Glucose Sensor Market Size is forecast to reach $ 14619.6 Million by 2030, at a CAGR of 9.4% during forecast period 2024-2030 primarily attributed to growing number of diabetic patients.
About IndustryARC™:
IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.
Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: [email protected]
USA: (+1) 518-282-4727